Antimicrobial Resistance urges NHS to test “subscription-like” payment model for treatments

UK Government recently announced details for how they plan to support pharmaceutical companies’ investments in the development of drugs to treat antibiotic resistant infections. The NHS looks to test a first-of-its-kind ‘subscription-style’ payment model that will help incentivise companies to develop new drugs required for tackling antibiotic resistant infections. The plan arose after the launch

Continue Reading